Does BARICITINIB Cause Therapy non-responder? 49 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Therapy non-responder have been filed in association with BARICITINIB (Olumiant). This represents 0.6% of all adverse event reports for BARICITINIB.
49
Reports of Therapy non-responder with BARICITINIB
0.6%
of all BARICITINIB reports
7
Deaths
9
Hospitalizations
How Dangerous Is Therapy non-responder From BARICITINIB?
Of the 49 reports, 7 (14.3%) resulted in death, 9 (18.4%) required hospitalization, and 8 (16.3%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BARICITINIB. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does BARICITINIB Cause?
Drug ineffective (569)
Off label use (479)
Covid-19 (347)
Pulmonary embolism (288)
Rheumatoid arthritis (284)
Headache (216)
Herpes zoster (216)
Pneumonia (216)
Death (206)
Deep vein thrombosis (201)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which BARICITINIB Alternatives Have Lower Therapy non-responder Risk?
BARICITINIB vs BARIUM
BARICITINIB vs BARNIDIPINE
BARICITINIB vs BASILIXIMAB
BARICITINIB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH
BARICITINIB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED